Health hazard evaluation report: HETA-98-0048-2688, the Children's Hospital, Denver, Colorado.
Cincinnati, OH: U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, HETA 98-0048-2688, 1998 Apr; :1-26
In response to a request from Denver's Children's Hospital management, the National Institute for Occupational Safety and Health (NIOSH) conducted an industrial hygiene evaluation of health care worker's exposures to aerosolized ribavirin. Rivabirin is a synthetic nucleoside that is used to prevent and treat respiratory syncytial virus (RSV) infections in infants and children. The specific request was for NIOSH to evaluate exposures to ribavirin and determine if N-95 disposable respirators should be used to provide supplemental protection against exposure to the drug. At Children's Hospital, ribavirin is frequently administered through the Airlife face mask enclosed by an aerosol scavenging system (a NOVA Tenthouse cube attached to the hospital's suction system).
Region-8; Hazard-Unconfirmed; Health-hazard-evaluation; Hospitals; Ribavivrin; Nucleosides; Respirators; Industrial-hygiene; Exposures; Air-sampling;
Author Keywords: General Medical and Surgical Hospitals; ribavirin; Virazole; 1-beta-D-ribofuranosyl- 1,2,4-triazole-3-carboximide; aerosolized drugs; aerosolized pharmaceuticals; health care workers; aerosol containment system
Field Studies; Hazard Evaluation and Technical Assistance
NTIS Accession No.
National Institute for Occupational Safety and Health